8-K: Primerica Reports Strong Fourth Quarter 2023 Results Driven by Sales Force Growth

Primerica's fourth quarter 2023 results show a 9% increase in diluted earnings per share and a record life-licensed sales force of 141,572, driven by strong recruiting and licensing momentum.

Summary

• Primerica announced its financial results for the quarter ended December 31, 2023, with total revenues reaching $726.3 million, a 6% increase compared to the same period in 2022.
• Net income for the quarter was $151.9 million, up 4%, and earnings per diluted share (EPS) increased by 9% to $4.30.
• Adjusted operating revenues were $724.3 million, also a 6% increase, while adjusted net operating income rose by 4% to $150.4 million.
• Adjusted operating earnings per diluted share increased by 9% to $4.25.
• The company's life-licensed sales force grew to a record 141,572, a 5% increase year-over-year, with 88,757 new term life insurance policies issued, a 12% increase.
• The total face amount of issued term life policies increased by 16% to $29.3 billion.
• Investment and Savings Product sales increased by 13% to $2.4 billion, and client asset values reached $96.7 billion, a 15% increase.
• For the full year 2023, Primerica recruited nearly 362,000 individuals, resulting in a 9% increase in new insurance licenses and a 5% growth in the life-licensed sales force.
• Full year net income was $576.6 million, a 23% increase, with diluted EPS of $15.94, a 29% increase.
• Adjusted net operating income for the year was $581.4 million, an 8% increase, and adjusted operating EPS was $16.07, a 15% increase.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong growth in key areas such as sales force, life insurance policies, and investment products. While there are some challenges in the senior health segment, the overall tone is optimistic and indicates a healthy financial position.

Positives

• The company experienced strong recruiting and licensing trends, indicating the attractiveness of its business model.
• The large and stable block of in-force term life insurance policies contributed positively to the financial results.
• Higher investment product sales and appreciation of client asset values boosted revenues.
• Net investment income was higher due to increased interest rates and growth in the investment portfolio.
• The company's share repurchase program demonstrates a commitment to returning value to shareholders.
• The statutory risk-based capital ratio of 435% indicates a strong financial position for the insurance company.

Negatives

• The senior health segment experienced a small loss due to lower sales from a less tenured agent mix.
• The company continues to experience pressures in senior health, resulting in a 28% decline in revenues for the segment.
• The company experienced elevated lapse rates in term life insurance, likely due to higher costs of living, although the impact on the fourth quarter was minimal.
• Investment product sales declined 8% year-over-year due to volatile equity markets in the first half of 2023.

Risks

• The company faces risks related to attracting and retaining sales representatives, and maintaining their licenses.
• Changes in laws or regulations could impact the distribution model and require modifications to the structure.
• Litigation and regulatory investigations could pose challenges.
• Differences between actual experience and expectations regarding mortality, persistency, and disability could affect pricing.
• Failure to meet regulatory capital ratios or a significant downgrade by a ratings organization could have adverse effects.
• The company is exposed to risks related to the performance of reinsurers and investment products.
• Economic downcycles, public health pandemics, and cyber-attacks could disrupt business operations.
• The company is exposed to risks related to the performance of e-TeleQuote and changes to Medicare Advantage.
• Fluctuations in the market price of the company's common stock or Canadian currency exchange rates could impact the company.

Future Outlook

The company believes 2024 holds exciting opportunities to build momentum, particularly as they work toward their biennial convention in July. They also expect amounts ceded under the IPO coinsurance transactions to continue to decline over time as policies terminate within this block of business.

Management Comments

• Glenn Williams, Chief Executive Officer of Primerica, Inc., stated that the company's financial results during the fourth quarter reflected the benefit of a large and stable block of in-force term life insurance policies, higher investment products sales and appreciation of client asset values.
• Glenn Williams also noted that the company continued to experience pressures in senior health, resulting in a small loss in the segment.
• Glenn Williams believes 2024 holds exciting opportunities to build momentum as they work toward their biennial convention in July.

Industry Context

Primerica's results reflect a trend of increased demand for financial products and services, particularly in the middle-income market. The growth in the sales force and investment product sales indicates a strong position in the market. However, the challenges in the senior health segment highlight the competitive nature of that market and the need for effective strategies to address those challenges.

Comparison to Industry Standards

• Primerica's 5% growth in its life-licensed sales force is a strong indicator of its ability to attract and retain talent, which is crucial in the insurance industry. Companies like Northwestern Mutual and New York Life also rely on large agent networks, but their growth rates may vary.
• The 12% increase in issued term life policies and 16% increase in face amount issued demonstrates strong sales performance, which is comparable to other large term life insurers such as Prudential and Transamerica.
• The 13% increase in investment product sales and 15% increase in client asset values are competitive with other financial services companies like Edward Jones and Ameriprise Financial, which also focus on wealth management and investment products.
• The senior health segment's challenges are not unique, as many companies in the health insurance space face similar pressures related to agent productivity and policy approvals. Companies like Humana and UnitedHealth Group also operate in this space and face similar challenges.
• Primerica's statutory risk-based capital (RBC) ratio of 435% is a strong indicator of financial health, which is comparable to other well-capitalized insurance companies. A ratio above 300% is generally considered healthy.

Stakeholder Impact

• Shareholders will benefit from the strong financial results and the share repurchase program.
• Employees and sales representatives will benefit from the company's growth and success.
• Customers will benefit from the company's financial products and services.
• Creditors will be reassured by the company's strong financial position.

Next Steps

• The company will hold a webcast on February 14, 2024, to discuss the quarter's results.
• The company will continue to execute its $425 million share repurchase program through December 31, 2024.
• The company will work towards its biennial convention in July 2024.

Key Dates

Keywords

Primerica, financial results, life insurance, sales force, investment products, earnings per share, share repurchase, senior health, client assets, term life insurance